Tech Company Financing Transactions

Aldexa Therapeutics Funding Round

Domain Associates invested in a $3 million funding round for Aldexa Therapeutics. The funding round was recorded on 6/30/2010.

Transaction Overview

Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
$3,039,400
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15 New England Executive Park
Burlington, MA 01803
USA
Email Address
Not Recorded
Overview
Aldexa Therapeutics was founded in 2012 based on the insight that aldehydes are pivotal upstream mediators of major medical diseases. The ability to capture and remove aldehydes from causing toxic damage has the potential to treat a number of diseases as well as prevent disease progression.
Profile
Aldexa Therapeutics LinkedIn Company Profile
Social Media
Aldexa Therapeutics Company Twitter Account
Company News
Aldexa Therapeutics News
Facebook
Aldexa Therapeutics on Facebook
YouTube
Aldexa Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Todd Brady
  Todd Brady LinkedIn Profile  Todd Brady Twitter Account  Todd Brady News  Todd Brady on Facebook
Chief Operating Officer
Scott Young
  Scott Young LinkedIn Profile  Scott Young Twitter Account  Scott Young News  Scott Young on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2010: Corventis venture capital transaction
Next: 6/30/2010: Optiwind venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary